Yeah I have read it and it’s largely about the trial protocol rather than any news.
there are 3 main parts to the article:
1. Overview of Pathophysiology of heart failure
2. Overview of how MSC’s may work to improve patient with heart failure including phase 2 results
3. How the trial is structured and how that structure compares to previous trials in heart failure
nothing to write home about in any of it to be competetely honest but it’s good for MSB to get their name out there I guess.
Yeah I have read it and it’s largely about the trial protocol...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
0.043(4.13%) |
Mkt cap ! $1.221B | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.09 | $1.03 | $4.989M | 4.672M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 1941 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.08 | 59816 | 28 |
View Market Depth
| Last trade - 15.15pm 02/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |